| P2093 | author name string | D C Powers | |
| | E D Kilbourne | |
| | B E Johansson | |
| P2860 | cites work | Reduction in plaque size and reduction in plaque number as differing indices of influenza virus-antibody reactions | Q27490194 |
| | Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations | Q33907707 |
| | Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins | Q34350453 |
| | Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection | Q36781677 |
| | Role of influenza vaccination in the elderly during an epidemic of A/H1N1 virus in 1988-1989: clinical and serological data | Q36785457 |
| | Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase | Q37129134 |
| | Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum | Q37138345 |
| | Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. | Q37200967 |
| | Lessons from a Nursing Home Outbreak of Influenza A | Q39268292 |
| | IgG subclass changes in response to vaccination | Q39744122 |
| | Determinants of immunity to influenza infection in man | Q39784922 |
| | Biological activities of immunoglobulins of different classes and subclasses. | Q39949391 |
| | Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition | Q40047277 |
| | A Controlled Double-Blind Comparison of Reactogenicity, Immunogenicity, and Protective Efficacy of Whole-Virus and Split-Product Influenza Vaccines in Children | Q40821102 |
| | Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans | Q40883203 |
| | Different Protection Rates in Various Groups of Volunteers Given Subunit Influenza Virus Vaccine in 1976 | Q41036382 |
| | Neuraminidase Content of Influenza Vaccines and Neuraminidase Antibody Responses after Vaccination of Immunologically Primed and Unprimed Populations | Q41037179 |
| | Host defenses against influenza virus: the role of anti-hemagglutinin antibody | Q43771891 |
| | Serum IgG subclass responses of humans to inactivated and live influenza A vaccines compared to natural infections with influenza A. | Q44595394 |
| | Association of serum anti-neuraminidase antibody with resistance to influenza in man. | Q44693807 |
| | Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans | Q44817736 |
| | Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine | Q44899333 |
| | Reduced Infectivity of Cold-Adapted Influenza A H1N1 Viruses in the Elderly: Correlation with Serum and Local Antibodies | Q44967688 |
| | Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans | Q45279547 |
| | In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant | Q45771723 |
| | Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine | Q45780300 |
| | Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults | Q45785388 |
| | Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus | Q45804747 |
| | Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees | Q45830670 |
| | Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody | Q45836300 |
| | Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults. | Q52547988 |
| | Influenza neuraminidase antibody patterns of man. | Q54027647 |
| | Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine | Q54467457 |
| | An outbreak of influenza A (H3N2) in a well immunized nursing home population | Q57111648 |
| | Antigenicity of Licensed Whole Virion and Subvirion Influenza Vaccines in "High Risk" Persons | Q67446227 |
| | Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines | Q72809083 |
| | Effect of neuraminidase antibody on Hong Kong influenza | Q93737304 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 511-516 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults | |
| P478 | volume | 3 | |